BOLT

Bolt Biotherapeutics
NASDAQHEALTHCAREBIOTECHNOLOGY

Key Statistics

Market Cap
$7.72M
P/E Ratio
EPS
$-16.59
Beta
1.17
52W High
$7.20
52W Low
$3.75
50-Day MA
$4.38
200-Day MA
$4.98
Dividend Yield
Profit Margin
0.00%
Forward P/E
PEG Ratio

About Bolt Biotherapeutics

Bolt Biotherapeutics, Inc., a clinical-stage immuno-oncology company, is dedicated to the discovery, development and commercialization of pharmaceutical products. The company is headquartered in Redwood city, California.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$6.50M
Gross Profit (TTM)$-17.43M
EBITDA$-29.02M
Operating Margin-29235.00%
Return on Equity-88.80%
Return on Assets-28.10%
Revenue/Share (TTM)$3.59
Book Value$10.32
Price-to-Book0.39
Price-to-Sales (TTM)1.19
EV/Revenue1.085
EV/EBITDA0.93
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)-97.90%
Shares Outstanding$1.92M
Float$1.77M
% Insiders3.47%
% Institutions28.86%

Historical Volatility

HV 10-Day
80.03%
HV 20-Day
65.54%
HV 30-Day
67.10%
HV 60-Day
69.69%
HV Rank
39.3%

Volatility is currently expanding

Analyst Ratings

Consensus ($41.00 target)
2
Buy
2
Hold

Latest News

Bolt Metals Announces Closing of Option to Acquire the High-Grade Floralia Iron Project

VANCOUVER, BC / ACCESS Newswire / June 12, 2026 / Bolt Metals Corp. ("Bolt" or the "Company") (CSE:BOLT)(OTCQB:PCRCF)(FSE:A3D8AK), is pleased to announce that, further to its press releases dated May 13, 2026, the letter of intent dated October 23, 2025, and the definitive option agreement dated May 12, 2026, as amended (the "Option Agreement"), with Max Iron Brazil Ltd. ("MaxIron"), an entity controlled by Max Resource Corp. ("Max"), pursuant to which Bolt has the right to acquire 100% of the Florália High Purity Iron Property (title no.

Accesswire6/12/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on BOLT and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 7/29/2026